Study demonstrates potency of synthetic antibiotic against serious chronic infections

  04 January 2024

A new synthetic antibiotic developed by University of Liverpool researchers is shown to be more effective than established drugs against ‘superbugs’ such as MRSA, a new study shows.

The study demonstrates the potent activity of the antibiotic, teixobactin, against bacterial biofilms. Biofilms are clusters of bacteria that are attached to a surface and/or to each other – which are associated with serious chronic infections in humans.

Further reading: University of Liverpool
Author(s): University of Liverpool
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed